# Sideris Pharmaceuticals, Inc. — Form D

Sideris Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-24. The offering totals $32.0M, of which $17.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-10-24
- Form: D
- Accession: 0001140361-13-039479
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $32.0M
- Amount sold: $17.0M
- Remaining: $15.0M
- Investors: 6
- Date of first sale: 2013-10-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-205211

## Issuer

- Name: Sideris Pharmaceuticals, Inc.
- CIK: 0001587658
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: C/O MPM CAPITAL, BOSTON, MA, 02116
- Phone: 617-425-9232

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Ansbert K Gadicke | Director | Boston, MA |
| Douglas K Reed | Director | Durham, NC |
| Kazumi Shiosaki | Director | Watertown, MA |
| Kazumi Shiosaki | Executive Officer | Watertown, MA |
| Thomas Neenan | Director | Lexington, MA |
| Thomas Neenan | Promoter | Lexington, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2013-09-27](https://search.stillhousedata.com/formd/0001140361-13-037103) | D | $599K | $599K |

## More

- [CIK 1587658 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1587658&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-13-039479.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.